Webinar | May 20, 2022

Navigating Regulatory Direct-to-Patient Considerations

Source: Medidata, a Dassault Systemes company

Clinical trials are undergoing a paradigm shift towards decentralization. Now the participant, rather than site, is at the center of the design and execution of a trial. Direct-to-patient supply is key to enabling clinical trial decentralization, whether partial or full in nature. Enabling DtP requires understanding the regulatory requirements and guidance to streamline planning and ensure a compliant and robust DtP process. This webinar aims to introduce the main regulatory themes, as well as provide a practical insight into converting regulatory theory to practical steps to enable DtP on global studies. 

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader